BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 37282629)

  • 1. Opportunities and considerations for studying liver disease with microphysiological systems on a chip.
    Otumala AE; Hellen DJ; Luna CA; Delgado P; Dissanayaka A; Ugwumadu C; Oshinowo O; Islam MM; Shen L; Karpen SJ; Myers DR
    Lab Chip; 2023 Jun; 23(13):2877-2898. PubMed ID: 37282629
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opportunities and challenges in the wider adoption of liver and interconnected microphysiological systems.
    Hughes DJ; Kostrzewski T; Sceats EL
    Exp Biol Med (Maywood); 2017 Oct; 242(16):1593-1604. PubMed ID: 28504617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications of microphysiological systems to disease models in the biopharmaceutical industry: Opportunities and challenges.
    Irrechukwu O; Yeager R; David R; Ekert J; Saravanakumar A; Choi CK
    ALTEX; 2023; 40(3):485-518. PubMed ID: 36648096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Engineering Organ-on-a-Chip Systems for Vascular Diseases.
    Shakeri A; Wang Y; Zhao Y; Landau S; Perera K; Lee J; Radisic M
    Arterioscler Thromb Vasc Biol; 2023 Dec; 43(12):2241-2255. PubMed ID: 37823265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microphysiological systems for human aging research.
    Park S; Laskow TC; Chen J; Guha P; Dawn B; Kim DH
    Aging Cell; 2024 Mar; 23(3):e14070. PubMed ID: 38180277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Organs-on-chips technologies - A guide from disease models to opportunities for drug development.
    Monteduro AG; Rizzato S; Caragnano G; Trapani A; Giannelli G; Maruccio G
    Biosens Bioelectron; 2023 Jul; 231():115271. PubMed ID: 37060819
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human organ chips for regenerative pharmacology.
    Goyal G; Belgur C; Ingber DE
    Pharmacol Res Perspect; 2024 Feb; 12(1):e01159. PubMed ID: 38149766
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular human organ-on-a-chip platform for disease modeling, drug development, and personalized therapy.
    Khanna A; Oropeza BP; Huang NF
    J Biomed Mater Res A; 2024 Apr; 112(4):512-523. PubMed ID: 37668192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Engineered Biomimetic Membranes for Organ-on-a-Chip.
    Rahimnejad M; Rasouli F; Jahangiri S; Ahmadi S; Rabiee N; Ramezani Farani M; Akhavan O; Asadnia M; Fatahi Y; Hong S; Lee J; Lee J; Hahn SK
    ACS Biomater Sci Eng; 2022 Dec; 8(12):5038-5059. PubMed ID: 36347501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. National reflection on organs-on-chip for drug development: New regulatory challenges.
    Teixeira SG; Houeto P; Gattacceca F; Petitcollot N; Debruyne D; Guerbet M; Guillemain J; Fabre I; Louin G; Salomon V
    Toxicol Lett; 2023 Oct; 388():1-12. PubMed ID: 37776962
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An Overview of Organ-on-a-Chip Models for Recapitulating Human Pulmonary Vascular Diseases.
    Nguyen T; Ahsan F
    Adv Exp Med Biol; 2023; 1413():265-272. PubMed ID: 37195535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in TEER measurements of biological barriers in microphysiological systems.
    Nazari H; Shrestha J; Naei VY; Bazaz SR; Sabbagh M; Thiery JP; Warkiani ME
    Biosens Bioelectron; 2023 Aug; 234():115355. PubMed ID: 37159988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An update on microfluidic multi-organ-on-a-chip systems for reproducing drug pharmacokinetics: the current state-of-the-art.
    Vasconez Martinez MG; Frauenlob M; Rothbauer M
    Expert Opin Drug Metab Toxicol; 2024 Jun; 20(6):459-471. PubMed ID: 38832686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascularized Microfluidics and Their Untapped Potential for Discovery in Diseases of the Microvasculature.
    Myers DR; Lam WA
    Annu Rev Biomed Eng; 2021 Jul; 23():407-432. PubMed ID: 33863238
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recent progress of organ-on-a-chip towards cardiovascular diseases: advanced design, fabrication, and applications.
    Wu H; Shi S; Liu Y; Zhang Q; Lam RHW; Lim CT; Hu J
    Biofabrication; 2023 Jul; 15(4):. PubMed ID: 37267929
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microfluidics and Organ-on-a-Chip for Disease Modeling and Drug Screening.
    Nasiri R; Zhu Y; de Barros NR
    Biosensors (Basel); 2024 Feb; 14(2):. PubMed ID: 38392005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Microfluidic organ-on-a-chip models of human liver tissue.
    Moradi E; Jalili-Firoozinezhad S; Solati-Hashjin M
    Acta Biomater; 2020 Oct; 116():67-83. PubMed ID: 32890749
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New horizons of microphysiological systems: India forging its path in human-relevant research.
    Parvatam S; Mahadik K; Banerjee A; Patil K; Radha V; Rao M
    Biol Open; 2023 Apr; 12(4):. PubMed ID: 37070566
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liver microphysiological platforms for drug metabolism applications.
    Kulsharova G; Kurmangaliyeva A
    Cell Prolif; 2021 Sep; 54(9):e13099. PubMed ID: 34291515
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Challenges and Opportunities in the Design of Liver-on-Chip Microdevices.
    Ehrlich A; Duche D; Ouedraogo G; Nahmias Y
    Annu Rev Biomed Eng; 2019 Jun; 21():219-239. PubMed ID: 31167098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.